Refining docetaxel-containing therapy for gastric cancer. - Wikidata - awgldk - TriplyDB

Refining docetaxel-containing therapy for gastric cancer.

Refining docetaxel-containing therapy for gastric cancer.

http://www.wikidata.org/entity/Q35445166

about

Outcomes of third-line docetaxel-based chemotherapy in advanced gastric cancer who failed previous oxaliplatin-based and irinotecan-based chemotherapies.

P2860

Q36536982-D9D00BB5-67C7-4697-BD2D-A2739FBDC71B

P2860

Refining docetaxel-containing therapy for gastric cancer.

http://www.wikidata.org/entity/Q35445166

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Refining docetaxel-containing therapy for gastric cancer.

@ast

Refining docetaxel-containing therapy for gastric cancer.

@en

type

label

Refining docetaxel-containing therapy for gastric cancer.

@ast

Refining docetaxel-containing therapy for gastric cancer.

@en

prefLabel

Refining docetaxel-containing therapy for gastric cancer.

@ast

Refining docetaxel-containing therapy for gastric cancer.

@en

P1433

Q35445166-4B24AF24-6AD1-4935-B748-0E7FD82458D8

P1476

Q35445166-D5289560-8E8B-424F-A505-6057812FA7E2

P2093

Q35445166-2CB99209-C5EB-4E3A-90D1-1AE1BB64D5FE

Q35445166-393E0276-F430-4ECE-9BD7-E26C9D47719E

Q35445166-4481307F-D7BC-4B29-83EC-38ED3E5A0FF3

Q35445166-55FFE025-E576-4857-B313-0B21F02DD7EE

Q35445166-71CD6308-EC70-4BEA-8A66-4C6E7FEBAC53

P2860

Q35445166-012F2AE3-92A3-4A86-8C4F-C20337CCDBEA

Q35445166-04078BAA-4F98-4684-B3A0-9F9331B4D576

Q35445166-06367462-279C-49AD-9159-628FEF8D9A7B

Q35445166-0DB7719E-E4DA-4A92-AC01-1776F018E34A

Q35445166-0E057DE1-085A-4090-B322-32ADECFF2FAF

Q35445166-303D75C5-E22A-4C2A-A60D-321677F3BDC6

Q35445166-3E44917D-23D6-4507-AB03-729A445CDDD2

Q35445166-3FAC8F0C-5CEF-4F3A-B823-75B04876E8F8

Q35445166-48952B11-0B45-4E0A-A905-603C25B7996E

Q35445166-4EFFD31F-7CE6-4034-9F05-FBF00EF2CA49

P304

Q35445166-E3D7D156-D9D3-4C97-B765-0EAE0A303FD2

P31

Q35445166-269AB8BD-2EE7-4CB0-9CE7-FD2F1CF0256D

P433

Q35445166-7894059A-680B-4E66-A04F-CA460D18E593

P478

Q35445166-8E3B7C39-38FD-448C-93DA-8C62465034ED

P577

Q35445166-F9333E00-A9EC-442B-93FF-5432B6419EEB

P698

Q35445166-06B3F830-9295-494B-89B8-5B273ACF9F8D

P932

Q35445166-E369A904-E028-4159-875B-5BB9185FD5D3

P1433

Gastrointestinal cancer research : GCR

P1476

Refining docetaxel-containing therapy for gastric cancer

@en

P2093

Al B Benson

http://www.w3.org/2001/XMLSchema#string

Jaffer A Ajani

http://www.w3.org/2001/XMLSchema#string

Mary F Mulcahy

http://www.w3.org/2001/XMLSchema#string

Nushmia Z Khokhar

http://www.w3.org/2001/XMLSchema#string

Yixing Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.

Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203.

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer.

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research.

Epidemiology of upper gastrointestinal malignancies.

Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.

P304

96-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22043325

http://www.w3.org/2001/XMLSchema#string

P932

3201643

http://www.w3.org/2001/XMLSchema#string